Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met
- 1 November 2003
- journal article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 10 (11), 840-849
- https://doi.org/10.1038/sj.cgt.7700640
Abstract
Engineered retroviruses are widely used vectors for cancer gene therapy approaches. However, the ability to target cells of therapeutic interest while controlling the expression of the transferred genes would improve both the efficiency and the safety of viral vectors. In this study, we investigated the ability of a retroviral amphotropic envelope displaying single-chain variable-fragment (scFv) directed against the c-Met receptor, to target the entry of recombinant retroviruses to human hepatocarcinoma cells. Four single-chain antibody fragments directed against the c-Met receptor were generated and inserted into the viral envelope protein as an N-terminal fusion. The modified envelopes were incorporated into virus particles and one of the chimeric viruses, 3D6-Env, transduced preferentially human hepatoma cells rather than proliferating human hepatocytes. In another construct, the urokinase cleavage site was inserted between the scFv moiety and the envelope. Chimeric scFv-urokinase-Env viruses transduced hepatoma cells with a similar efficiency to that of the control virus and their infectivity in human hepatocytes remained low. These results indicate that amphotropic retroviruses with engineered envelopes to display scFv directed against the c-Met receptor can efficiently and selectively deliver genes into hepatoma cells.Keywords
This publication has 29 references indexed in Scilit:
- Transcription-targeted gene therapy for androgen-independent prostate cancerCancer Gene Therapy, 2002
- Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovirCancer Gene Therapy, 2001
- Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approachCancer Gene Therapy, 2000
- Cre-loxP-mediated bax gene activation reduces growth rate and increases sensitivity to chemotherapeutic agents in human gastric cancer cellsCancer Gene Therapy, 2000
- Strategies to Adapt Adenoviral Vectors for Targeted DeliveryAnnals of the New York Academy of Sciences, 1999
- Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administrationGene Therapy, 1998
- Inverse Targeting of Retroviral Vectors: Selective Gene Transfer in a Mixed Population of Hematopoietic and Nonhematopoietic CellsBlood, 1998
- Expression of ?-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapyHepatology, 1998
- In VitroandIn VivoHepatoma Cell-Specific Expression of a Gene Transferred with an Adenoviral VectorHuman Gene Therapy, 1996
- The Basic Science of Gene TherapyScience, 1993